TetraQ is a leading Australian preclinical contract research organization focused on providing a broad range of integrated preclinical drug development solutions in the disciplines of ADME, Bioanalytics, Efficacy, Toxicology and Pharmaceutics. TetraQ’s Toxicology, ADME and Bioanalytics laboratories are GLP recognised and in collaboration with NATA, TetraQ’s ADME team pioneered ISO17025-2005 (R&D) research & development accreditation becoming the first laboratory in Australia to obtain this accreditation in 2005.
Each of our world-class facilities is equipped with state-of-the-art instrumentation including LC-MS/MS, HPLC & ELISA. Essentially, TetraQ is a one-stop-shop for early stage drug development and we are recognized as world leaders in bioanalytical method development & sample analysis of drugs / metabolites in biological fluids with both human and animal samples.
SCYNEXIS Overview 2010: Fully Integrated Drug Discovery CRO Solutionsbrycechaney
SCYNEXIS, Inc. is a fully-integrated drug discovery and development CRO located in Research Triangle Park, NC with 120,000 sq.ft. of state-of-the-art facilities and equipment. SCYNEXIS is registered with both the FDA and DEA.
ClinActis Pte Ltd is a full service CRO providing clinical trial services to the pharmaceutical, medical device, medical nutrition and biotech companies in Asia Pacific. Established in 2009, ClinActis Pte Ltd is headquartered in Singapore.
ClinActis Experience
• 45 years experience in clinical research in pharmaceutical and biotechnology companies as well as CROs
• 28 years experience in Asia Pacific, including Australia/New Zealand, China, Malaysia, Hong Kong, India, Indonesia, The Philippines, Singapore, South Korea, Taiwan, Thailand and Japan
• Extensive knowledge of regulatory frameworks, best KOLs and sites across the region
• Vast therapeutic experience including Cardiovascular, CNS, Endocrinology, Infectious diseases, Oncology, and Respiratory
Ethocle Reports has published its latest Market Research Report on Deep Brain Stimulators - Medical Devices Pipeline Assessment, 2016. Formulate significant competitor information, analysis, and insights to improve R&D strategies. Browse market data tables and figures.
Innovative Drug Pipeline Solutions: Medicinal Chemistry, Process Chemistry, cGMP API Manufacturing. 105+ global clients. 120,000 sq.ft. facilities located in Research Triangle Park, NC USA. FDA inspected and DEA registered.
This webinar will focus on understanding the time and cost of custom media and proprietary off-the-shelf media. We will cover such things as:
- The upfront and long-term cost of custom and proprietary off-the-shelf media
- Why custom media is worth the investment and reduces long-term costs
- Two case studies for custom media
SCYNEXIS Overview 2010: Fully Integrated Drug Discovery CRO Solutionsbrycechaney
SCYNEXIS, Inc. is a fully-integrated drug discovery and development CRO located in Research Triangle Park, NC with 120,000 sq.ft. of state-of-the-art facilities and equipment. SCYNEXIS is registered with both the FDA and DEA.
ClinActis Pte Ltd is a full service CRO providing clinical trial services to the pharmaceutical, medical device, medical nutrition and biotech companies in Asia Pacific. Established in 2009, ClinActis Pte Ltd is headquartered in Singapore.
ClinActis Experience
• 45 years experience in clinical research in pharmaceutical and biotechnology companies as well as CROs
• 28 years experience in Asia Pacific, including Australia/New Zealand, China, Malaysia, Hong Kong, India, Indonesia, The Philippines, Singapore, South Korea, Taiwan, Thailand and Japan
• Extensive knowledge of regulatory frameworks, best KOLs and sites across the region
• Vast therapeutic experience including Cardiovascular, CNS, Endocrinology, Infectious diseases, Oncology, and Respiratory
Ethocle Reports has published its latest Market Research Report on Deep Brain Stimulators - Medical Devices Pipeline Assessment, 2016. Formulate significant competitor information, analysis, and insights to improve R&D strategies. Browse market data tables and figures.
Innovative Drug Pipeline Solutions: Medicinal Chemistry, Process Chemistry, cGMP API Manufacturing. 105+ global clients. 120,000 sq.ft. facilities located in Research Triangle Park, NC USA. FDA inspected and DEA registered.
This webinar will focus on understanding the time and cost of custom media and proprietary off-the-shelf media. We will cover such things as:
- The upfront and long-term cost of custom and proprietary off-the-shelf media
- Why custom media is worth the investment and reduces long-term costs
- Two case studies for custom media
Anthony Presentation DIA Florida Ctd Nov2007AKTaylor
Creating a business process that is accurate, predictable, and capable of
meeting the changing needs for disclosing information about clinical trials
in multiple study registries and results databases is difficult. Companies
need to leverage their current clinical trial process, determine if the disclosure
steps will be centralized or decentralized, determine how much to
leverage technology, and decide whether, and how, to use outside
resources. During this session, we will hear how a large pharma, a small
biopharmaceutical company, and a device company developed their clinical
trial disclosure business process.
Thermo Fisher Scientific India Pvt. Ltd. (NYSE: TMO) is the world leader in serving science, with revenues of $18 billion and approximately 55,000 employees globally. Our mission through our premier brands Thermo Scientific, Applied Bio Systems, Invitrogen, Fisher Scientific and Unity Lab Services, we offer an unmatched combination of innovative is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. We offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support.
Clinical Research Organization Services | Contract Research Company - PepgraPEPGRA Healthcare
Pepgra is a global contract research organization and drug development services company. It provides various phases of clinical research trials services to pharmaceutical and biotechnology companies to help reduce the time and costs associated with drug development.
Contact Us:
Website : https://bit.ly/33Fwsye
Email us: sales.cro@pepgra.com
India: +91 9884350006
United Kingdom: +44- 74248 10299
The Sentieon Genomic Tools - Improved Best Practices Pipelines for Analysis o...Golden Helix
With next-generation sequence datasets frequently reaching petabytes in size, processing genomic data accurately and efficiently is increasingly a major computational bottleneck. The Sentieon Genomics Tools provide a solution to this bottleneck with a reimplementation of the mathematics underlying the GATK Best Practices pipelines for calling variants from germline or tumor-normal paired samples.
The Sentieon Genomics Tools provide identical results to the GATK pipelines with a 10x reduction in runtime, a robust software implementation, and deterministic data processing. This webcast will explore the benefits of the Sentieon Genomics Tools including a discussion of the results of the PrecisionFDA Truth and Consistency challenges and the ICGC-TCGA DREAM Mutation Calling Challenge for somatic SNV, indel, and structural variants.
Golden Helix has partnered with Sentieon to integrate its secondary analysis tools with Golden Helix software to provide users with a comprehensive solution for genomic data analysis. In this webinar, Dr. Andreas delves into the new partnership, followed by an overview of the Sentieon software by Dr. Donald Freed.
Anthony Presentation DIA Florida Ctd Nov2007AKTaylor
Creating a business process that is accurate, predictable, and capable of
meeting the changing needs for disclosing information about clinical trials
in multiple study registries and results databases is difficult. Companies
need to leverage their current clinical trial process, determine if the disclosure
steps will be centralized or decentralized, determine how much to
leverage technology, and decide whether, and how, to use outside
resources. During this session, we will hear how a large pharma, a small
biopharmaceutical company, and a device company developed their clinical
trial disclosure business process.
Thermo Fisher Scientific India Pvt. Ltd. (NYSE: TMO) is the world leader in serving science, with revenues of $18 billion and approximately 55,000 employees globally. Our mission through our premier brands Thermo Scientific, Applied Bio Systems, Invitrogen, Fisher Scientific and Unity Lab Services, we offer an unmatched combination of innovative is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. We offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support.
Clinical Research Organization Services | Contract Research Company - PepgraPEPGRA Healthcare
Pepgra is a global contract research organization and drug development services company. It provides various phases of clinical research trials services to pharmaceutical and biotechnology companies to help reduce the time and costs associated with drug development.
Contact Us:
Website : https://bit.ly/33Fwsye
Email us: sales.cro@pepgra.com
India: +91 9884350006
United Kingdom: +44- 74248 10299
The Sentieon Genomic Tools - Improved Best Practices Pipelines for Analysis o...Golden Helix
With next-generation sequence datasets frequently reaching petabytes in size, processing genomic data accurately and efficiently is increasingly a major computational bottleneck. The Sentieon Genomics Tools provide a solution to this bottleneck with a reimplementation of the mathematics underlying the GATK Best Practices pipelines for calling variants from germline or tumor-normal paired samples.
The Sentieon Genomics Tools provide identical results to the GATK pipelines with a 10x reduction in runtime, a robust software implementation, and deterministic data processing. This webcast will explore the benefits of the Sentieon Genomics Tools including a discussion of the results of the PrecisionFDA Truth and Consistency challenges and the ICGC-TCGA DREAM Mutation Calling Challenge for somatic SNV, indel, and structural variants.
Golden Helix has partnered with Sentieon to integrate its secondary analysis tools with Golden Helix software to provide users with a comprehensive solution for genomic data analysis. In this webinar, Dr. Andreas delves into the new partnership, followed by an overview of the Sentieon software by Dr. Donald Freed.
Developing and maintaining strong relationships between the Sponsor and the selected CRO can make or break a clinical study. In this webinar, two experts with experience managing clinical programs from both a CRO and a Sponsor perspective provide tips and strategies for optimizing these relationships using real world examples.
A presentation outlining the various processes a chemical compound undergoes (thorough & rigorous screening procedures) before it is finally introduced into the drug market
Well-trained clinical research professionals are in high demand. The tremendous increase in medical technology and information in the last decade has resulted in an explosion of potential new drugs, devices and biologics that must be tested before being released for use by the public. The profession is constantly challenged to improve and streamline the clinical research programs in order to shorten the development timelines and control the cost for new product development
QPS is a GLP/GCP-compliant contract research organization (CRO) supporting discovery, preclinical and clinical drug development. We provide quality services to pharmaceutical and biotechnology clients worldwide.
Thanks to its combination of clinical pharmacology and bioanalytical services, QPS Netherlands has broad experience in performing dose-escalating (first-in-man) and drug-drug interaction studies with rapid turnaround of time-sensitive PK and biomarker samples.
High Quality Integrated Drug R&D Servicesmedicilonz
End-to-end services and solutions covering the entire spectrum of preclinical biopharmaceutical R&D. Supporting everything from target discovery, candidate development, preclinical screening and drug safety evaluation through IND submission. https://www.medicilon.com/about-medicilon/
General Manager and Executive Director of clinical studies conducted at ALS Inc.
PK expertise and extensive experience in clinical development of Phase 1 to 3 and bioequivalence studies.
KPS Clinical Services (KPSCS) is set up by the RAHE Group of Organizations, with an aim to become one of the India's leading research-based Contract Research Organization (CRO). Our commitment is to improve the quality of human life & to provide world class clinical research services to pharmaceutical, biotechnology, medical device companies, academic and government organizations.
We wish to focus on the prevailing issues in clinical research & give their solutions with a fresh and rational approach. In this endeavor, we have successfully established a team of highly qualified and experienced multi-disciplinary GCP trained personnel. The services provided by KPSCS are knowledge-driven and based on the understanding of the pharmacology and molecular basis of disease. We believe in providing quality services & we prioritize customer relationships.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
TetraQ - Integrated Preclinical Drug Development Solutions Presentation
1. What is TetraQ?
A leading Australian contract research organisation (CRO)
providing integrated preclinical drug development
services to the biotech and pharmaceutical industries
where...
Quality, Performance, Reliability and Value are more
than just words to us...
It’s everything!
Quality Preclinical Drug Development Solutions
2. Where is TetraQ?
Brisbane
Located at The University of Queensland in
Brisbane (UQ), Queensland
Joint initiative of UQ, Qld Institute for Medical
Research (QIMR) and Q-Pharm
Part funded by the Queensland Government
Smart State Research Facilities Fund
8.1 M$ invested in State-of-the-art infrastructure
GLP recognized
Staffing – 30 FTE + casuals
Quality Preclinical Drug Development Solutions
3. How was TetraQ founded?
4 Founders
Professors Ron Dickinson, Istvan Toth, Rod
Minchin & Maree Smith
Internationally recognized experts in the
four core preclinical disciplines –
• ADME
• Efficacy
• Toxicology
• Pharmaceutics
100 yrs expertise & know-how amongst
founders
60 yrs of commercialization experience
amongst founders
Quality Preclinical Drug Development Solutions
4. How is TetraQ structured?
Centre for Integrated Preclinical Drug Development (CIPDD)
Training
The Hub of Organics Research
Analysis
Short courses for
Targeted to bringing Commercial arm of
Industry CIPDD; Business
Bioanalysis Services innovation into Drug
Development “Toolkit” undertaking contract
for UQ researchers
R&D for biotech &
i.e. methods research
Preclinical Seminars Pharma clients
Modern GLP facilities
with the latest Funded by research
Training of PhD Registered business
equipment and highly grants: Govt + Industry
name of UniQuest -
students working on
trained technical staff
“toolkit research” contracting entity
for services to
University of QLD
researchers
Quality Preclinical Drug Development Solutions
5. What is the significance of TetraQ services?
Assess potential therapeutic effects of the drug candidate in living
organisms
Gather sufficient data to determine reasonable safety of the drug
candidate in humans through laboratory experimentation and
animal studies
Determine whether the drug candidate is ever likely to be
developed as a pharmaceutical
“Fail early, fail cheap”
Quality Preclinical Drug Development Solutions
6. Why is this significant?
Expensive exercise – $US 800 – 1200 million
Long timelines – 10-15 yrs
Huge risk of failure
Only 1 in 5000 molecules from drug discovery will
make it to market and become a new product
Quality Preclinical Drug Development Solutions
7. What are the services TetraQ provide?
Assessment of:
Efficacy:
“Does it work?”
Cell-based assays and animal models of human disease
ADME - Pharmacokinetics and metabolism:
“How can it be delivered and what does the body do to it?”
Absorption, distribution, metabolism, elimination (ADME)
Toxicology:
“Is it safe?”
Cell-based assays and animal testing
Pharmaceutics:
“Is its manufacture viable and controllable?”
Physicochemical properties; formulation studies, stability
Quality Preclinical Drug Development Solutions
8. Where does TetraQ fit into the drug development phases?
Phase
Preclinical Phase I Phase II
III
Drug
Drug Discovery Clinical Clinical
Clinical
Development Trials Trails
Trails
Quality Preclinical Drug Development Solutions
9. Efficacy – Biological Services
Is the drug candidate effective against the target disease?
Proof-of-concept studies in animal models of human disease
Pain: nociceptive, inflammatory, neuropathic
Arthritis
CNS Models - Multiple sclerosis, Parkinson‟s disease
Obesity
Diabetes
Cancer (through partner)
Quality Preclinical Drug Development Solutions
10. Pharmaceutics
Does the drug candidate have the right physical, chemical &
biological properties to become a medicine for human use?
Physicochemical characterization
FTIR, UV,NMR,MS
Formulation development
Structure elucidation, solubility
Stability trials & stability indicating method development
Dissolution studies
Lead compound optimisation
Quality Preclinical Drug Development Solutions
11. Toxicology
TetraQ-Toxicology facilities are GLP recognised
Is the drug candidate sufficiently safe to administer to humans in
early stage clinical trials ?
Genotoxicity assays (Ames Test, Micronucleus, Mouse Lymphoma
Assay)
In vivo acute & repeat dose (chronic) toxicity studies
In vivo safety pharmacology (including hERG, respiratory and CNS)
Cytotoxicity assessment
In vivo – two species, rodent and non rodent (dog, primates)
Project Management Services
Preclinical development plans
Quality Preclinical Drug Development Solutions
12. ADME – Bioanalytic Services
(absorption, distribution, metabolism elimination)
TetraQ-ADME is GLP recognised & has NATA ISO 17025, Research
& Development Accreditation
World leaders in bioanalytical method development &
sample analysis of drugs/metabolites in biological
fluids, human and animal samples
Validated bioanalytical methods
HPLC, LC-MS/MS, ELISA
Screening, partially validated, fully validated to
satisfy FDA requirements
Bioavailability and pharmacokinetic studies
Drug metabolism studies including metabolite
identification
Biodistribution and plasma protein binding studies
Toxicokinetics
Quality Preclinical Drug Development Solutions
13. What Clinical trail experience does TetraQ have?
HAHA Assay
Transferred and validated HAHA assay (Human antibody/human antibody)
and anaylsed 100‟s of samples
ELISA Assay (Only Australian laboratory accredited for ELISA)
Transferred and conducted partial validation of ELISA assay for major
Australian biotech organisations with analysis of 1500 plasma samples
LC-MS/MS - 3 synthetic peptides in a single vaccine
Fully validated in rat plasma to FDA requirements
Analysis of samples from Toxicokinetic study
Small molecules - LC-MS/MS
Bioequivalence studies for generics
Quality Preclinical Drug Development Solutions
14. Quality is Key!
Our Quality System is maintained by a full-time Quality
Assurance Manager who is supported by trained QA staff in
each facility
TetraQ-ADME - NATA ISO 17025, Research & Development
Accreditation
TetraQ-ADME and TetraQ-Toxicology are GLP recognised
facilities
Data acceptable for Australian and international regulatory
submission
Quality Preclinical Drug Development Solutions
15. Who are TetraQ clients?
Australian biotech and pharma companies
ASX-listed & private companies
International clients
Based in USA, Europe, Asia & Japan
Universities, Research Institutes, Big Pharma
200 projects for 60 clients since inception in May 2005
Frequent repeat business
Indicates strong client satisfaction
Quality Preclinical Drug Development Solutions
16. Why use TetraQ Services?
TetraQ offer Tailored solutions, not just a menu of choices
Four world class facilities with quot;State of the art” equipment including
LC-MS/MS, HPLC and ELISA equipment
Highly skilled scientific and management team,
Services backed by a leadership team with wealth experience in all
4 areas of preclinical drug development
Quality science behind all services (no short cuts)
Modern PC2, SPF central animal breeding facilities
We assist clients with data interpretation to facilitate and guide timely
decision-making
A „one-stop shop‟ for early stage drug development
Quality Preclinical Drug Development Solutions
17. Thank you for your interest in TetraQ
We are focused to provide preclinical drug
Dean Simonsen
- Sales & Services Manager
development solutions to meet your needs
- Mb: 61 409 480 532
- Email: d.simonsen@tetraq.com.au
- PH: 61 7 3346 9933
- Fx: 61 7 3346 7391
Please feel free to ask questions to
Rose-marie Pennisi
better understand how we may assist
- Commercial Manager
- Mb: 61 437 112 549
your organisation
- Email: r.pennisi@tetraq.com.au
Quality Preclinical Drug Development Solutions